8-K - Outlook Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Outlook Therapeutics, Inc. filed an 8-K on March 11, 2026, disclosing the resignation of Dr. Julia Haller effective March 6, 2026, under Item 5.02, with her resignation letter attached as Exhibit 99.1. This executive departure may impact leadership continuity.

Key Takeaways

1Dr. Julia Haller resigned effective March 6, 2026.

2Resignation letter dated March 6, 2026, filed as Exhibit 99.1.

3Disclosure under Item 5.02: Departure of Directors or Certain Officers.

4Filing date: March 11, 2026.

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 6, 2

Management Change

Company or the Company

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Resignation letter dated March 6, 2026, from Dr. Julia Haller. 104 Cover Page Inter

Exhibits Only

Source Document

Executive & Director Changes

Dr. Julia Haller

resigned

Effective: 2026-03-06

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1